Open Access
Open access
volume 9 issue 6 pages 1306

Antiviral Efficacy of Ribavirin and Favipiravir against Hantaan Virus

Jennifer Mayor 1, 2
Olivier B Engler 2
Sylvia Rothenberger 1, 2
Publication typeJournal Article
Publication date2021-06-15
scimago Q2
wos Q2
SJR1.009
CiteScore7.7
Impact factor4.2
ISSN20762607
Microbiology (medical)
Microbiology
Virology
Abstract

Ecological changes, population movements and increasing urbanization promote the expansion of hantaviruses, placing humans at high risk of virus transmission and consequent diseases. The currently limited therapeutic options make the development of antiviral strategies an urgent need. Ribavirin is the only antiviral used currently to treat hemorrhagic fever with renal syndrome (HFRS) caused by Hantaan virus (HTNV), even though severe side effects are associated with this drug. We therefore investigated the antiviral activity of favipiravir, a new antiviral agent against RNA viruses. Both ribavirin and favipiravir demonstrated similar potent antiviral activity on HTNV infection. When combined, the efficacy of ribavirin is enhanced through the addition of low dose favipiravir, highlighting the possibility to provide better treatment than is currently available.

Found 
Found 

Top-30

Journals

1
2
3
Viruses
3 publications, 12%
International Journal of Molecular Sciences
1 publication, 4%
Infectious Diseases and Therapy
1 publication, 4%
EBioMedicine
1 publication, 4%
Frontiers in Pediatrics
1 publication, 4%
ACS Nano
1 publication, 4%
Antimicrobial Agents and Chemotherapy
1 publication, 4%
Infection and Drug Resistance
1 publication, 4%
Journal of Biomolecular Structure and Dynamics
1 publication, 4%
Antibiotiki i Khimioterapiya
1 publication, 4%
Frontiers in Veterinary Science
1 publication, 4%
Biosciences Biotechnology Research Asia
1 publication, 4%
Virus Research
1 publication, 4%
Pharmaceutics
1 publication, 4%
Transplant Infectious Disease
1 publication, 4%
Russian Chemical Reviews
1 publication, 4%
Antiviral Research
1 publication, 4%
Molecular Diversity
1 publication, 4%
Frontiers in Immunology
1 publication, 4%
COVID
1 publication, 4%
PLoS Pathogens
1 publication, 4%
Transboundary and Emerging Diseases
1 publication, 4%
Biochemical and Biophysical Research Communications
1 publication, 4%
1
2
3

Publishers

1
2
3
4
5
6
MDPI
6 publications, 24%
Elsevier
4 publications, 16%
Frontiers Media S.A.
3 publications, 12%
Springer Nature
2 publications, 8%
Taylor & Francis
2 publications, 8%
Wiley
2 publications, 8%
American Chemical Society (ACS)
1 publication, 4%
American Society for Microbiology
1 publication, 4%
Publishing House OKI
1 publication, 4%
Oriental Scientific Publishing Company
1 publication, 4%
Autonomous Non-profit Organization Editorial Board of the journal Uspekhi Khimii
1 publication, 4%
Public Library of Science (PLoS)
1 publication, 4%
1
2
3
4
5
6
  • We do not take into account publications without a DOI.
  • Statistics recalculated weekly.

Are you a researcher?

Create a profile to get free access to personal recommendations for colleagues and new articles.
Metrics
25
Share
Cite this
GOST |
Cite this
GOST Copy
Mayor J. et al. Antiviral Efficacy of Ribavirin and Favipiravir against Hantaan Virus // Microorganisms. 2021. Vol. 9. No. 6. p. 1306.
GOST all authors (up to 50) Copy
Mayor J., Engler O. B., Rothenberger S. Antiviral Efficacy of Ribavirin and Favipiravir against Hantaan Virus // Microorganisms. 2021. Vol. 9. No. 6. p. 1306.
RIS |
Cite this
RIS Copy
TY - JOUR
DO - 10.3390/microorganisms9061306
UR - https://doi.org/10.3390/microorganisms9061306
TI - Antiviral Efficacy of Ribavirin and Favipiravir against Hantaan Virus
T2 - Microorganisms
AU - Mayor, Jennifer
AU - Engler, Olivier B
AU - Rothenberger, Sylvia
PY - 2021
DA - 2021/06/15
PB - MDPI
SP - 1306
IS - 6
VL - 9
PMID - 34203936
SN - 2076-2607
ER -
BibTex |
Cite this
BibTex (up to 50 authors) Copy
@article{2021_Mayor,
author = {Jennifer Mayor and Olivier B Engler and Sylvia Rothenberger},
title = {Antiviral Efficacy of Ribavirin and Favipiravir against Hantaan Virus},
journal = {Microorganisms},
year = {2021},
volume = {9},
publisher = {MDPI},
month = {jun},
url = {https://doi.org/10.3390/microorganisms9061306},
number = {6},
pages = {1306},
doi = {10.3390/microorganisms9061306}
}
MLA
Cite this
MLA Copy
Mayor, Jennifer, et al. “Antiviral Efficacy of Ribavirin and Favipiravir against Hantaan Virus.” Microorganisms, vol. 9, no. 6, Jun. 2021, p. 1306. https://doi.org/10.3390/microorganisms9061306.